Home | Books | Health Store | Resources | News

Archive

World on alert as bird flu (H5N1 virus) reaches Europe

For the last two months health authorities and government leaders around the globe have been holding hastily arranged cabinet meetings and medical conferences in a desperate attempt to prepare for what many fear is an inevitable influenza pandemic that the world is ill prepared to cope with. As communicable disease experts carefully scrutinize daily medical reports for the first signs of the impending pandemic, public health specialists and manufacturers are working frantically to develop vaccines, drugs, and strategies to quarantine and treat the ill. Unfortunately, all of these plans will take several years to implement, and the most dangerous strain of influenza to appear in decades -- the H5N1 "bird flu" in Asia -- is showing up in new populations of birds, and occasionally people, on an almost daily basis.

Driving this unparalleled level of international cooperation is the simple fact that a global influenza pandemic has nothing in common with the relatively mild forms of flu that appear every year. Common influenza is caused by well-known strains of flu that have circulated through the human population for decades or longer. Since humans already possess broad immunity to these garden-variety strains, they can only cause reinfection by slightly altering their genes from year to year, usually resulting in only mild discomfort. Pandemic influenza, on the other hand, is a rare and deadly form of virus that can only arise after a new strain from an animal source mixes its genes with a common human bug to produce a completely new strain that is highly contagious, extremely deadly, and to which people have absolutely no prior immunity


Thankfully, flu pandemics are relatively rare – only four occurred in all of the 20th century. But given that it has been more than 40 years since the last pandemic many health experts believe that the time is ripe for a new outbreak. Such concerns are heightened by the rapid spread of a new contagious microbe known as influenza H5N1, or avian (bird) flu. After first being detected in wild birds in Asia, avian flu has recently passed through Siberia, into Rumania, and is now moving across Europe.
So far the human death toll from avian flu has been low, and confined to people in close contact with infected birds. But a number of scientists are warning of a major pandemic if the H5N1 virus mutates into a form capable of being transmitted between humans. "Every time a new person gets infected with the virus there is a small chance that person will trigger a pandemic," said Neil Ferguson, a scientist at London’s Imperial College who has been running simulations to predict what will happen when H5N1 to reach Britain. And while some scientists believe the chances are low, researchers discovered that the strain of H5N1 isolated in Rumania has already mutated into a version that is more easily transmitted to humans. Adding to the bad news, medical authorities in Asia recently reported of a case where they believe H5N1 was passed from one person to another.

Global Medical Community not Prepared for Pandemic

The "Spanish flu" pandemic of 1918 killed an estimated 100 million people. If such an outbreak were to occur today many health experts predict that the combination of increased population density (3 times higher than in 1918) and rapid global travel could spread the virus across the globe in a matter of days and make containment almost impossible. The problem would be further exacerbated by the shortage of effective antiviral drugs and vaccines. According to even the most optimistic estimates, current supplies of vaccines and drugs are far too low to control a major outbreak, let alone contain a full-fledged global pandemic.

Writing in the July 31, 2005 Washington Post, reporter David Brown points out that “if the virus were to start spreading in the next year, the world would have only a relative handful of doses of an experimental vaccine to defend against a disease that, history shows, could potentially kill millions. If the vaccine proved effective and every flu vaccine factory in the world started making it, the first doses would not be ready for four months. By then, the pathogen would probably be on every continent. Theoretically, antiviral drugs could slow an outbreak and buy time. The problem is only one licensed drug, oseltamivir (Tamiflu), appears to work against bird flu. At the moment, there is not enough stockpiled for widespread use. Nor is there a plan to deploy the small amount that exists in ways that would have the best chance of slowing the disease.”

Currently there is no vaccine that can protect against the H5N1 avian flu virus because scientists do not yet know what the final strain will be. According to The Guardian some manufacturers are working on general H5N1 vaccines which they hope would provide some protection in the event of a pandemic, but these remain unproven. Making matters even worse, a new strain of the bird flu virus recently isolated from an infected Vietnamese girl has been determined to be resistant to Tamiflu, the aforementioned drug that health officials are counting on to combat an avian influenza pandemic.

In light of a lack of adequate treatments, U.S. public health specialists are drawing up unprecedented countermeasures to slow the spread of a pandemic, including vaccinating only children; mandatory closing of schools or office buildings; and imposing quarantines on infected families to prohibit them from leaving their homes. And around the globe authorities are drafting similar drastic measures to contain an outbreak, including restricting international travel, shutting down public transit systems and nationalizing supplies of critical medical equipment, such as surgical masks.

Herbal Formula Effective in Hong Kong Health Crisis

While Western health experts and drug companies try to cope with a lack of vaccines and antiviral drugs, emergency health authorities in China have been quietly stockpiling a unique anti-viral herbal formula that has already been shown to be effective for protecting those at highest risk of infection during a viral outbreak — the front-line doctors and nurses who risk their lives to control the outbreak. When SARS first appeared in Hong Kong in March 2003, the disease proved incredibly difficult to treat. Antibiotics and standard antiviral drugs, including a powerful combination of the anti-viral drug ribavirin and steroids, turned out to be totally ineffective. Compounding the SARS crisis was the alarming discovery that front-line healthcare workers were especially vulnerable — up to 25% of all cases were the very doctors and nurses caring for the ill.

Confronted with a deadly, highly virulent virus that was resistant to conventional treatments, Hong Kong health authorities desperately sought out any means for treating the new disease. Then in mid-April officials noted a curious anomaly — even as doctors and nurses at Western-style hospitals continued to become sick, their medical peers staffing the traditional Chinese medicine clinics throughout Hong Kong were remaining healthy and infection-free despite working in close proximity to infected patients. As the authorities quickly learned, the clinic workers were boosting their immune systems to prevent infection by taking a unique antiviral herbal formula that had been produced by medical experts at the city’s Chinese University.

Within days hospital authorities had rushed 40,000 doses of the formula to at-risk health care workers across the city, while a special team of epidemiologists from the University of Hong Kong monitored the workers to track their exposure to the virus. After two weeks the researchers reported the blood samples revealed that not even a single health worker had contracted the infection after taking the herbal formula. Additionally, the blood samples showed that the formula was significantly boosting the workers immunological functions, indicating an ability to prevent viral infection at the very earliest stages of exposure. The epidemiological team concluded that their evaluation indicated that the herbal formula was a suitable preparation for preventing influenza-like infections.

Natural Antiviral Herbal Support for Colds and Flu

The formula used in Hong Kong was based on the work of one of the leading experts of modern Chinese medicine (and the inventor of Vital Cell), Dr. Dexin Yan. In 1990 Dr. Yan launched an intensive study of the effects of three traditional cold and flu formulas. The first, Yin Chiao, was shown to be effective for stopping a cold if taken at the first sign of an infection. The second formula, Gan Mao Ling, was found to significantly reduce the duration of a cold or flu if taken after infection had already set in. And the last formula, Zhong Gan Ling, turned out to be extremely effective for treating the flu, especially when present with a high fever.

Dr. Yan combined the best elements of all three formulas. Additionally, he increased the amount of three important medicinal herbs, ilex, isatis, and forsythia, that new research has shown exert powerful, antiviral actions. Dr. Yan then went to the next step, adding elements from a fourth formula, Pe Min Kan Wan, which acts as an effective nasal decongestant.

After extensive testing and clinical evaluation to determine the precise percentage of each herbal ingredient, Dr. Yan finally arrived at a single formula that stops colds or flu when taken at the first sign, and speeds up recovery when taken after a cold or flu has already started. Best of all, reports from Dr. Yan’s patients revealed that the formula was especially effective at alleviating such common symptoms as nasal congestion, headaches and stuffy head symptoms, without the side effects of over-the-counter medications.

Anti-Viral Formula now Available in the United States

Dr. Yan’s formula is now available in the U.S. as ImmunoPhase. Unlike over-the-counter cold and flu medications that cover up and/or suppress the miserable symptoms of a cold or flu, ImmunoPhase offers a powerful, proactive response to colds and flu. By enhancing the immune system during the first signs of infection, ImmunoPhase aids in repelling the virus before it has a chance to spread. And in addition to being highly effective at preventing illness when taken at the first signs of an impending cold or flu, ImmunoPhase has also been shown to relieve symptoms and enhance the immune system for a more rapid recovery when taken after one has already caught a cold or flu.

ImmunoPhase Ingredients and Actions

  1. Angelica root – nasal/sinus congestion, headache
  2. Artemesia plant – fever
  3. Forsythia fruit – sore throat, fever, headache
  4. Gypsum fiber – high fever, irritability, thirst, cough, wheezing
  5. Honeysuckle flower – sore throat, headache, fever, antiviral, antibacterial
  6. Ilex root – antitussive and expectorant for coughs, fever, headache, antiviral
  7. Isatis root – painful, swollen throat, antibacterial, antiviral
  8. Magnolia flower – nasal/sinus congestion
  9. Notopterygii root and rhizome – chills, fever, headache, body aches
  10. Pueraria root – fever, headache, stiff neck, thirst
  11. Verbenae stem and leaf – swollen throat
  12. Xanthii fruit – opens nasal passages, nasal/sinus discharge, headache

Dosage and Safety of ImmunoPhase

ImmunoPhase™ is an advanced herbal formula that offers effective immune support for fighting off colds and flu. ImmunoPhase is completely free of side effects and use will not make one feel sleepy, cause drowsiness or otherwise impair function. Since the formula is stimulant-free its use does not contribute to irritability, impair sleep or interfere with blood pressure medications [as might compounds containing pseudoephedrine].

Adults: At the first signs of a cold or flu, take two capsules every 2-3 hours

Children age 6-12: Take one capsule every 3 hours at the first sign of a cold or flu.

When taken after cold or flu have already developed, continue with the recommended dosage to reduce symptoms and speed recovery.

ImmunoPhase, 60 caps……………$24.95

Order ImmunoPhase Now…

 

       

The content provided by this site is for informational purposes only and has
not been approved by the U.S. FDA. This site is not intended to provide
personal medical advice, which should be obtained from a medical professional.

©2008 cassmd.com, all rights reserved.